%0 Journal Article
%A Kamposioras, Konstantinos
%A Mauri, Davide
%A Papadimitriou, Konstantinos
%A Anthoney, Alan
%A Hindi, Nadia
%A Petricevic, Branka
%A Dambrosio, Mario
%A Valachis, Antonis
%A Kountourakis, Pantelis
%A Kopecky, Jindrich
%A Kuhar, Cvetka Grašič
%A Popovic, Lazar
%A Chilingirova, Nataliya P
%A Zarkavelis, George
%A de Mello, Ramon Andrade
%A Plavetić, Natalija Dedić
%A Christopoulos, Christos
%A Mostert, Bianca
%A Goffin, John R
%A Tzachanis, Dimitiros
%A Saraireh, Haytham Hamed
%A Ma, Fei
%A Pavese, Ida
%A Tolia, Maria
%T Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth
%D 2020
%U http://hdl.handle.net/10668/3419
%X Introduction: Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support decision making, pertaining to the oncologic care in the middle of a global outbreak.Methods: We did an international online search in twenty five countries that have managed a surge in cancer patient numbers. We collected the recommendations from thirty one medical oncology societies.Results: By synthesizing guidelines for a) oncology service delivery adjustments, b) general and specific treatment adaptations, and c) discrepancies from guidelines comparison, we present a clinical synopsis with the forty more crucial statements. A Covid-19 risk stratification base was also created in order to obtain a quick, objective patient assessment and a risk-benefit evaluation on a case-by-case basis.Conclusions: In an attempt to face these complex needs and due to limited understanding of COVID-19, a variability of recommendations based on general epidemiological and infectious disease principles rather than definite cancer-related evidence has evolved. Additionally, the absence of an effective treatment or vaccine requires the development of cancer management guidance, capitalizing on comprehensive COVID-19 oncology experience globally.
%K Covid-19
%K Recommendations
%K International
%K Oncology
%K Societies
%K Infecciones por coronavirus
%K Directrices para la planificación en salud
%K Internacionalidad
%K Instituciones oncológicas
%K Sociedades médicas
%~